181 related articles for article (PubMed ID: 34811953)
1. Risk stratification in heart failure decompensation in the community: HEFESTOS score.
Verdu-Rotellar JM; Abellana R; Vaillant-Roussel H; Gril Jevsek L; Assenova R; Kasuba Lazic D; Torsza P; Glynn LG; Lingner H; Demurtas J; Thulesius H; Muñoz MA;
ESC Heart Fail; 2022 Feb; 9(1):606-613. PubMed ID: 34811953
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure.
Voors AA; Ouwerkerk W; Zannad F; van Veldhuisen DJ; Samani NJ; Ponikowski P; Ng LL; Metra M; Ter Maaten JM; Lang CC; Hillege HL; van der Harst P; Filippatos G; Dickstein K; Cleland JG; Anker SD; Zwinderman AH
Eur J Heart Fail; 2017 May; 19(5):627-634. PubMed ID: 28247565
[TBL] [Abstract][Full Text] [Related]
3. Multistate Model to Predict Heart Failure Hospitalizations and All-Cause Mortality in Outpatients With Heart Failure With Reduced Ejection Fraction: Model Derivation and External Validation.
Upshaw JN; Konstam MA; Klaveren Dv; Noubary F; Huggins GS; Kent DM
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27514751
[TBL] [Abstract][Full Text] [Related]
4. Precipitating factors of heart failure decompensation, short-term morbidity and mortality in patients attended in primary care.
Verdu-Rotellar JM; Vaillant-Roussel H; Abellana R; Jevsek LG; Assenova R; Lazic DK; Torsza P; Glynn LG; Lingner H; Demurtas J; Borgström B; Gibot-Boeuf S; Muñoz MA
Scand J Prim Health Care; 2020 Dec; 38(4):473-480. PubMed ID: 33201746
[TBL] [Abstract][Full Text] [Related]
5. Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance.
Thorvaldsen T; Claggett BL; Shah A; Cheng S; Agarwal SK; Wruck LM; Chang PP; Rosamond WD; Lewis EF; Desai AS; Lund LH; Solomon SD
Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29242352
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure.
Simpson J; Jhund PS; Lund LH; Padmanabhan S; Claggett BL; Shen L; Petrie MC; Abraham WT; Desai AS; Dickstein K; Køber L; Packer M; Rouleau JL; Mueller-Velten G; Solomon SD; Swedberg K; Zile MR; McMurray JJV
JAMA Cardiol; 2020 Apr; 5(4):432-441. PubMed ID: 31995119
[TBL] [Abstract][Full Text] [Related]
7. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.
Lee DS; Austin PC; Rouleau JL; Liu PP; Naimark D; Tu JV
JAMA; 2003 Nov; 290(19):2581-7. PubMed ID: 14625335
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
9. Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients with Mechanical Circulatory Support) Right-Sided Heart Failure Risk Score.
Soliman OII; Akin S; Muslem R; Boersma E; Manintveld OC; Krabatsch T; Gummert JF; de By TMMH; Bogers AJJC; Zijlstra F; Mohacsi P; Caliskan K;
Circulation; 2018 Feb; 137(9):891-906. PubMed ID: 28847897
[TBL] [Abstract][Full Text] [Related]
10. H2FPEF Score as a Prognostic Value in HFpEF Patients.
Sueta D; Yamamoto E; Nishihara T; Tokitsu T; Fujisue K; Oike F; Takae M; Usuku H; Takashio S; Arima Y; Suzuki S; Nakamura T; Ito M; Kanazawa H; Sakamoto K; Kaikita K; Tsujita K
Am J Hypertens; 2019 Oct; 32(11):1082-1090. PubMed ID: 31271191
[TBL] [Abstract][Full Text] [Related]
11. Machine Learning Prediction of Mortality and Hospitalization in Heart Failure With Preserved Ejection Fraction.
Angraal S; Mortazavi BJ; Gupta A; Khera R; Ahmad T; Desai NR; Jacoby DL; Masoudi FA; Spertus JA; Krumholz HM
JACC Heart Fail; 2020 Jan; 8(1):12-21. PubMed ID: 31606361
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the German and Italian Stress Cardiomyopathy Score for Risk Stratification for In-hospital Complications in Patients With Takotsubo Syndrome.
Santoro F; Núñez Gil IJ; Stiermaier T; El-Battrawy I; Guerra F; Novo G; Guastafierro F; Tarantino N; Novo S; Mariano E; Romeo F; Romeo F; Capucci A; Bahlmann E; Zingaro M; Cannone M; Caldarola P; Marchetti MF; Montisci R; Meloni L; Thiele H; Di Biase M; Almendro-Delia M; Sionis A; Akin I; Eitel I; Brunetti ND
JAMA Cardiol; 2019 Sep; 4(9):892-899. PubMed ID: 31389988
[TBL] [Abstract][Full Text] [Related]
13. A one-year mortality clinical prediction rule for patients with heart failure.
Escobar A; García-Pérez L; Navarro G; Bilbao A; Quiros R;
Eur J Intern Med; 2017 Oct; 44():49-54. PubMed ID: 28637595
[TBL] [Abstract][Full Text] [Related]
14. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
[TBL] [Abstract][Full Text] [Related]
15. Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction.
Agarwal R; Shah SJ; Foreman AJ; Glassner C; Bartolome SD; Safdar Z; Coslet SL; Anderson AS; Gomberg-Maitland M
J Heart Lung Transplant; 2012 May; 31(5):467-77. PubMed ID: 22221678
[TBL] [Abstract][Full Text] [Related]
16. Meta-Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction.
Rich JD; Burns J; Freed BH; Maurer MS; Burkhoff D; Shah SJ
J Am Heart Assoc; 2018 Oct; 7(20):e009594. PubMed ID: 30371285
[TBL] [Abstract][Full Text] [Related]
17. External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure.
Salah K; Stienen S; Moons AHM; Bakx ALM; van Pol PE; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayes-Genis A; Pinto YM; Tijssen JG; Kok WE
J Am Heart Assoc; 2019 Jul; 8(14):e010309. PubMed ID: 31296084
[TBL] [Abstract][Full Text] [Related]
18. A novel prognostic index to determine the impact of cardiac conditions and co-morbidities on one-year outcome in patients with heart failure.
Senni M; Santilli G; Parrella P; De Maria R; Alari G; Berzuini C; Scuri M; Filippi A; Migliori M; Minetti B; Ferrazzi P; Gavazzi A
Am J Cardiol; 2006 Oct; 98(8):1076-82. PubMed ID: 17027575
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the HEFESTOS scale to predict outcomes in emergency department acute heart failure patients.
Gil-Rodrigo A; Verdú-Rotellar JM; Gil V; Alquézar A; Llauger L; Herrero-Puente P; Jacob J; Abellana R; Muñoz MÁ; López-Díez MP; Ivars-Obermeier N; Espinosa B; Rodríguez B; Fuentes M; Tost J; López-Grima ML; Romero R; Müller C; Peacock W; Llorens P; Miró Ò;
Intern Emerg Med; 2022 Oct; 17(7):2129-2140. PubMed ID: 36031673
[TBL] [Abstract][Full Text] [Related]
20. Burden of Heart Failure Signs and Symptoms, Prognosis, and Response to Therapy: The PARAGON-HF Trial.
Jering K; Claggett B; Redfield MM; Shah SJ; Anand IS; Martinez F; Sabarwal SV; Seferović PM; Kerr Saraiva JF; Katova T; Lefkowitz MP; Pfeffer MA; McMurray JJV; Solomon SD
JACC Heart Fail; 2021 May; 9(5):386-397. PubMed ID: 33714741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
